Neuro-Dol collaborates closely with academic and industrial partners locally, nationally and internationally to advance research in neuroscience and pain treatment.
At Neurodol, we are committed to improving the treatment of chronic pain, a major public health challenge impacting individuals and society. Using a reverse translational research approach, we transform clinical observations into therapeutic innovations.
Follow the latest news from Neuro-Dol: discover our research advances, imminent events and major contributions in the field of neuroscience and pain management
Track « Integrative Biology, Physiopathologies » Proposal for a Master 2 internship – 2025-2026 Title Contribution of the satellite glial cells in PACAP-induced migraine-like symptoms Summary : PACAP (pituitary adenylate cyclase-activating polypeptide) has emerged as a key mediator in migraine, but its mechanism remains unknown. The aim of this study is to assess the contribution of the trigeminal satellite glial…
Mise à jours des interventions aux Neuro-Dol Seminar : Programme ici :
L’Equipe 2, Douleur Trigéminale et migraine, ouvre 2 sujets de thèse pour octobre 2025, financés par des allocations de recherches UCA. Sujet 1 : Le tryptophane : un acteur clé dans l’efficacité antimigraineuse des triptans ? Encadrement : CRISTINA ALBA DELGADO Début de la thèse le 1 octobre 2025 Date limite de candidature (à 23h59)…
For all your questions and requests for information, our team is here to help.
Explore collaboration, partnership or other information opportunities by contacting us today.
Directories
Our interdisciplinary team, made up of researchers and clinicians, is dedicated to improving pain treatments through translational research.
Director of Neuro-Dol
Assistant Professor
Assistant Professor
Assistant Professor